Saint -Antoine Hospital_Médecine Intensive Reanimation
Paris, 75012, France
Location status: Recruiting
NCT Number: NCT06384287
Tissue perfusion has been identified as an early prognosis factor in patients admitted to intensive care. However, little is known about the effects of different hemodynamic interventions performed in clinical routine on peripheral tissue perfusion.
The aim of this work is to study the kinetics of CRT and local skin blood flow following therapeutic intervention (fluid challenge, vasopressor or inotropic drug).
Interested in participating?
Request Info18 year and older
All sexes
Observational
Paris, 75012, France
Location status: Recruiting
Sepsis is today a major cause of morbidity and mortality worldwide. Septic shock, the most serious manifestation of the infection, affects 2 to 20% of intensive care patients. Despite appropriate antibiotic therapy and improved resuscitation strategies based on early treatment, volume expansion and rational use of vasopressors, the mortality rate of shock states remains too high, between 40 and 50%.
Over the past two decades, great advances have been made in the understanding the pathophysiology of septic shock. Microcirculatory abnormalities have been identified as the main cause of organ hypoperfusion and visceral failure leading to death. In addition, several studies in animals and humans have highlighted a discordance between systemic hemodynamic parameters and alterations of small vessels during shock suggesting that microvascular blood flow and tissue perfusion should be analyzed in patients with acute circulatory failure in association with blood pressure and cardiac output. Capillary refill time (CRT), is an easy-to-use, easy-to learn tool to evaluate peripheral tissue perfusion. CRT is a strong predictive factor of organ failure severity and poor outcome in critically ill patients with sepsis. A recent randomized trial reported promising results regarding the use of CRT to guide resuscitation. However, little is known about the impact of treatment on CRT. The aim of this work is to study the kinetics of CRT and local skin blood flow following therapeutic intervention (fluid challenge, vasopressor or inotropic drug).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: continuous monitoring during 1 hour maximum starting just before intervention
Measurement using laser doppler probe in the finger tip
Time frame: at baseline, 3 timepoints after starting interventions (10, 30 and 60 minutes)
Clinical measurement at bedside
Time frame: at baseline, 3 timepoints after starting interventions (10, 30 and 60 minutes)
Clinical measurement at bedside
Time frame: at baseline, at 10, 30 and 60 minutes after intervention
Measurement using laser doppler probe in the finger tip
Time frame: at baseline, at 10, 30 and 60 minutes after intervention
Laser doppler with skin probe and echocardiography
Time frame: at baseline, at 10, 30 and 60 minutes after intervention
Laser doppler with skin probe and arterial catheter
Contact information is provided by the study sponsor or research team.
Assistance Publique - Hôpitaux de Paris
Other
Effects of Therapeutic Hemodynamic Interventions on Peripheral Perfusion in Intensive Care
Acronym: INPPEREA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07546656
Acute Circulatory Failure, Fluid Responsiveness
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07346118
AKI - Acute Kidney Injury, Acute Circulatory Failure
View Trial DetailsNCT02050269
Acute Circulatory Failure, Pathologic Processes
Orléans, France
View Trial DetailsNCT03680963
Acute Circulatory Failure, Pathologic Processes
Argenteuil, France
View Trial Details